Showing results (1-10 of 204) with videos related to
Sort By:
Pageof 21
Journal of Clinical Medicine|August 12, 2022
Neuroendocrine Tumors: Challenges and Future PerspectivesGiuseppe Lamberti, Anna La SalviaJournal of Clinical Medicine|August 28, 2025
Updates on Pulmonary Neuroendocrine Carcinoids: Progress and PerspectivesAnna Scognamiglio, Arianna Zappi, Elisa Andrini, et al.Journal of Clinical Medicine|January 21, 2023
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative ReviewArianna Zappi, Irene Persano, Linda Galvani, et al.Endocrine|January 24, 2025
Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoidsLinda Galvani, Arianna Zappi, Sara Pusceddu, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|July 6, 2023
Precision medicine in gastroenteropancreatic neuroendocrine neoplasms: Where are we in 2023?Nicola Fazio, Anna La SalviaEndocrine Research|July 23, 2024
Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine NeoplasmsAnna La Salvia, Giuseppe FanciulliCurrent Medical Research and Opinion|February 21, 2025
Methodological challenges and clinical perspectives in evaluating new treatments for ultra rare cancersStefania Bellino, Anna La SalviaExpert Opinion on Emerging Drugs|May 29, 2025
Newly emerging tyrosine kinase inhibitors for the treatment of neuroendocrine neoplasmsNicola Fazio, Anna La SalviaEndocrine Reviews|October 9, 2025
Immune checkpoint inhibitors in high-grade gastroenteropancreatic neuroendocrine neoplasmsNicola Fazio, Anna La SalviaFrontiers in Endocrinology|April 6, 2026
Beyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasmsAnna La Salvia, Giuseppe FanciulliPageof 21